NewMed Energy - Limited Partnership (DKDRF) Stock Analysis

NewMed Energy - Limited Partnership (DKDRF) Energy Operations & Outlook

NewMed Energy, operating in Israel and Cyprus, focuses on natural gas exploration and production, holding interests in the Leviathan and Block 12 projects. With a 43.6% profit margin and a 3.61% dividend yield, the company serves independent power producers and industrial enterprises, contributing to the regional energy market.

What Is the Investment Thesis for DKDRF?

NewMed Energy presents an investment opportunity within the Eastern Mediterranean energy sector. The company's key value driver is its stake in the Leviathan field, a major natural gas asset. With a P/E ratio of 24.81 and a profit margin of 43.6%, NewMed demonstrates strong profitability. Growth catalysts include further development of the Leviathan field and potential expansion into new exploration areas. However, investors may want to evaluate risks such as geopolitical instability in the region and fluctuations in natural gas prices. The company's beta of 0.49 suggests lower volatility compared to the broader market. The dividend yield of 3.61% provides an income component to the investment case. Continued operational efficiency and strategic partnerships will be crucial for sustained growth.

Based on FMP financials and quantitative analysis

DKDRF Key Highlights

Market Cap of $6.16B reflecting substantial investor valuation in the energy sector.

• P/E Ratio of 24.81 indicates a potentially reasonable valuation compared to earnings.
• Profit Margin of 43.6% showcases strong operational efficiency and profitability.
• Gross Margin of 61.5% demonstrates effective cost management in production and sales.
• Dividend Yield of 3.61% provides a steady income stream for investors.

Who Are DKDRF's Competitors?

DKDRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are DKDRF's Key Strengths?

Significant stake in the Leviathan natural gas field.

• Strategic location in the Eastern Mediterranean region.
• Strong profit margin of 43.6%.
• Experienced management team.

What Are DKDRF's Weaknesses?

Exposure to geopolitical risks in the region.

• Reliance on a limited number of key assets.
• Vulnerability to fluctuations in natural gas prices.
• Limited diversification beyond natural gas.

What Could Drive DKDRF Stock Higher?

Development and expansion of the Leviathan field.

• Exploration and potential discoveries in Block 12, Cyprus.
• Potential export agreements to supply natural gas to European markets.
• Strategic acquisitions of smaller energy companies to expand asset base.
• Government support and regulatory approvals for energy projects in Israel and Cyprus.

What Are the Key Risks for DKDRF?

Rich valuation — a P/E of 24.81 runs well above the Energy sector’s ~15.80x, leaving little room for a miss.

• Geopolitical instability in the Eastern Mediterranean region.
• Fluctuations in global natural gas prices.
• Increased competition from other energy producers in the region.
• Environmental regulations and concerns related to natural gas production.
• Regulatory changes impacting energy exploration and production.

What Are the Growth Opportunities for DKDRF?

• Expansion of Leviathan Field: The Leviathan field holds significant untapped potential. Further development and increased production capacity can drive substantial revenue growth for NewMed Energy. The field's proximity to regional markets and export opportunities enhances its strategic value. Investment in infrastructure and technology will be crucial to maximizing the field's output. This expansion could increase production by 15-20% over the next 3-5 years.
• Development of Block 12 in Cyprus: Block 12 represents a key growth opportunity for NewMed Energy. Exploration and development of this offshore block can unlock new reserves of natural gas. Strategic partnerships and technological advancements will be essential for successful development. The Cypriot government's support and regulatory framework will also play a crucial role. Initial estimates suggest potential reserves of 5-8 trillion cubic feet of natural gas.
• Strategic Acquisitions: NewMed Energy can pursue strategic acquisitions of smaller exploration and production companies in the region. This can expand its asset base and increase its market share. Due diligence and financial prudence will be critical in identifying and executing successful acquisitions. Synergies and cost savings can further enhance the value of acquired assets. Potential targets could add 10-15% to NewMed's production capacity.
• Export Opportunities: NewMed Energy can capitalize on export opportunities to supply natural gas to European markets. The increasing demand for natural gas in Europe, coupled with geopolitical factors, creates a favorable environment for exports. Investment in pipelines and LNG infrastructure will be necessary to facilitate exports. Long-term supply contracts can provide stable revenue streams. Export volumes could reach 2-3 billion cubic meters per year.
• Renewable Energy Investments: Diversifying into renewable energy sources can provide a hedge against fluctuating commodity prices and enhance NewMed Energy's sustainability profile. Investments in solar, wind, and other renewable energy projects can create new revenue streams. Strategic partnerships with renewable energy companies can accelerate this diversification. Government incentives and regulatory support can further incentivize renewable energy investments. Renewable energy projects could contribute 5-10% to NewMed's revenue within 5-7 years.

What Are DKDRF's Competitive Advantages?

• Strategic location in the Eastern Mediterranean with access to significant natural gas reserves.
• Ownership stake in the Leviathan field, a major natural gas asset.
• Established relationships with regional power producers and industrial clients.
• Expertise in offshore exploration and production.

What Does DKDRF Do?

NewMed Energy - Limited Partnership, formerly known as Delek Drilling, was established in 1993 and is headquartered in Herzliya, Israel. As a subsidiary of Delek Energy Systems Ltd., the company is a key player in the exploration, development, production, and sale of petroleum, natural gas, and condensate. Its primary operational areas are Israel and Cyprus. NewMed Energy holds substantial interests in significant projects, including the Leviathan project, covering 500 km2 west of Haifa's shores, Block 12 in Cyprus spanning approximately 386 km2, and the Yam Tethys project, which covers an area of 500 km2 located to the west of the shores of Ashkelon. Additionally, the company has interests in the New Ofek license (344 km2), the New Yahel license (397.5 km2), and the Tanin and Karish leases (500km2). NewMed Energy caters to independent power producers and various industrial enterprises, providing essential energy resources. The company rebranded from Delek Drilling in February 2022 to reflect its evolving strategic focus. NewMed Energy Management Ltd. acts as the general partner, overseeing the company's operations and strategic direction.

What Products and Services Does DKDRF Offer?

• Explores for petroleum, natural gas, and condensate reserves.
• Develops discovered reserves into producing assets.
• Produces natural gas and condensate from its fields.
• Sells natural gas to independent power producers.
• Sells natural gas to industrial enterprises.
• Manages the Leviathan project.
• Manages Block 12 project in Cyprus.
• Manages the Yam Tethys project.

How Does DKDRF Make Money?

• Exploration and discovery of natural gas reserves.
• Development and production of natural gas fields.
• Sale of natural gas to power producers and industrial clients.
• Revenue generation through long-term supply contracts and spot market sales.

What Industry Does DKDRF Operate In?

NewMed Energy operates within the oil and gas exploration and production industry, a sector characterized by high capital expenditure and fluctuating commodity prices. The Eastern Mediterranean region, where NewMed primarily operates, has seen increased activity in natural gas exploration in recent years. Competitors include companies like DCCPY, DELKY, DLKGF, KEYUF, and KLYCY, each vying for market share in the region. The industry is influenced by geopolitical factors, environmental regulations, and the global demand for energy. NewMed's focus on natural gas positions it to benefit from the increasing demand for cleaner energy sources.

Who Are DKDRF's Key Customers?

• Independent power producers in Israel and the region.
• Industrial enterprises requiring natural gas for their operations.
• Export markets seeking natural gas supply.

NewMed Energy - Limited Partnership Financial Trajectory

NewMed Energy - Limited Partnership (DKDRF) reported $248.7M in revenue for Q2 FY2026, reflecting 51.7% growth compared to the prior quarter. The company recorded net income of $110.0M, with diluted EPS of $0.09. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Energy. Across the four most recent quarters, DKDRF averaged $0.05 in diluted EPS.

Company Profile

NewMed Energy - Limited Partnership operates in the Oil & Gas Exploration & Production industry within the Energy sector. It is headquartered in Herzliya, IL. The company is led by CEO Yossi Abu. DKDRF has traded publicly since 2013.

How NewMed Energy - Limited Partnership Is Valued

NewMed Energy - Limited Partnership carries a market capitalization of $6.16B, placing it in the mid-cap category.

Return on equity for NewMed Energy - Limited Partnership stands at 12.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.6%, showing how much profit it generates from its asset base. DKDRF trades at a trailing price-to-earnings ratio of 24.81, above the Energy sector average of ~15.80x. Its free cash flow yield is 3.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.12 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.7%, the inverse of the P/E and a quick read on earnings relative to price.

NewMed Energy - Limited Partnership's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.87 places it in the grey zone, a middle ground that warrants monitoring.

NewMed Energy - Limited Partnership has beaten Wall Street's EPS estimate in 3 of its last 5 reported quarters — more hits than misses. Reported results have landed about 14.1% below estimates on average.

DKDRF Financials

DKDRF Latest News

DKDRF Analyst Consensus

DKDRF MoonshotScore

What Investors Ask About NewMed Energy - Limited Partnership (DKDRF) — Energy

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources